ROCHESTER, N.Y., Nov. 4, 2009 (GLOBE NEWSWIRE) -- NaturalNano, Inc. (OTCBB:NNAN) (Frankfurt:N3N) announced today their success using Halloysite Natural Tubes (HNT) in a broad range of feasibility studies that expand the potential commercial markets for its proprietary Halloysite nanotubules.
Acting President and CEO James Wemett said, "I am excited about our technology and our customers' success. The tubular nature of Halloysite material offers customers a unique advantage, allowing the microtubes to be easily treated and separated. In the past, NaturalNano worked with customers to be their supply chain. We are now changing our Philosophy and concentrating on specific fields of use. We are working on specific products that can benefit from our material and our novel controlled release effect. Going forward, we plan on participating in the commercialization of these Nano related products.
Two recent assessment efforts for diverse uses were favorably reported by the respective customers. In the first, Dr. Mike King at Cornell University works on blood separation through microtubes for diagnosis and treatment of Cancer. He recently stated, "NaturalNano's proprietary Halloysite nanotubes have enhanced the cell adhesion of circulating cancer cells to reactive surfaces and are found to be non toxic to the cells." http://www.news.cornell.edu/stories/June09/GeneTherapy.html
Based on initial work with HNTs, Pierre Miasnik, President of Fiabila S.A., a world leader in the contract manufacture of cosmetics, commented, "NaturalNano's technology will enable Fiabila to continue our commitment to use natural ingredients in our products." Fiabila is using our loaded Halloysite nanotubes for a new line of nail polish being introduced in the spring. NaturalNano has a three year supply agreement.
Wemett added, "We have now shown the commercial viability of Halloysite nanotube technology in a range of products. We are aggressively looking for an acquisition that brings our technology forward to produce products using our HNT. Our Goal is to use NaturalNano Technology to commercialize products that will directly financially benefit our company."
About NaturalNano, Inc.
NaturalNano, Inc. (OTCBB:NNAN) (FWB:N3N) is a materials science company focused on developing and commercializing advanced nanocomposites. Based in Rochester, NY, the Company is focused on additive technologies and processes, including its proprietary Pleximer(TM) polymer additive, that add value to industrial polymers, plastics and composites, as well as consumer and industrial products. NaturalNano holds and licenses over 25 patents and applications, as well as proprietary know-how for extraction and separation processes, compositions, and derivatives of Halloysite and other nanotubes. Visit www.naturalnano.com for more information.
Cautionary Statement Regarding Forward-Looking Statements: This press release may contain forward-looking statements regarding future events and future performance of NaturalNano that involve risks and uncertainties that could materially affect actual results. This information is qualified in its entirety by cautionary statements and risk factors disclosure contained in certain of NaturalNano's filings with the Securities and Exchange Commission. The most recent annual reports on Form 10-KSB and quarterly reports on Form 10-QSB filed by NaturalNano provide information about these factors, which may be revised or supplemented in future reports to the SEC on those forms or on Form 8-K. We caution investors not to place undue reliance on forward-looking statements, and we do not undertake any obligation to update or otherwise revise any forward-looking statements, whether as a result of new information, future events, or other such factors that affect the subject of these statements, except where expressly required by law.